Genelux Corporation (GNLX)
Nasdaq: GNLX · Pharmaceutical Preparations · Westlake Village, CA · filing with the SEC since 2003
Who owns Genelux Corporation
As filed with the SECHolders of 5% or more
2
Armistice Capital, LLC holds 9.99% of Common Stock, $0.001 par value per share, as its SCHEDULE 13G filed Nov 14, 2025 says.
Directors and officers
11
report now, of 18 people on the record since 2023. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Armistice Capital, LLC
SCHEDULE 13G · filed Nov 14, 2025 · Common Stock, $0.001 par value per share
Aladar Szalay
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.001 per share · 8.4% in Jul 25, 2025
What GNLX reports owning in othersstakes of 5% or more, and other ties
Genelux Corporation reports no stake in another company in the record.
Insider tradesForm 4
28sales
0purchases
3sales on a scheduled plan
6people selling
$400,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 5, 2025 to Nov 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 19 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Zindrick Thomas | President and CEO | 6 | $100,000 | 0 | 0 | $0 |
| Thomas John | director | 3 | $100,000 | 3 | 0 | $0 |
| Cappello Joseph | Chief Technical Officer | 6 | $0 | 0 | 0 | $0 |
| Yu Tony | Chief Scientific Officer | 6 | $0 | 0 | 0 | $0 |
| Smalling Ralph | Head of Regulatory | 6 | $0 | 0 | 0 | $0 |
| Smither John W | director | 1 | $0 | 0 | 0 | $0 |